Spectral Medical Provides December Tigris Trial Update
140 patients enrolled. TORONTO, Canada – January 6, 2024 – Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT),a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company’s Tigris...
